IMMP ▲ +4.3% - Immutep Limited
$IMMP - Immutep Reports Encouraging Disease-Free Survival from EFTISARC-NEO Phase II Trial in Soft Tissue Sarcoma
18-NOV-2026 07:12 PM ET
Share this post
More filings for $IMMP
IMMP ▼ -7.4% - Immutep LimitedNov 10, 2026IMMP ▼ -8.9% - Immutep LimitedNov 10, 2026IMMP ▲ +23.2% - Immutep LimitedNov 8, 2026IMMP ▲ +0.7% - Immutep LimitedNov 5, 2026IMMP ▲ +0.6% - Immutep LimitedOct 28, 2026IMMP ▲ +1.4% - Immutep LimitedOct 13, 2026
View full $IMMP filing history →💬 Comments
Loading comments…
Leave a comment
